OPILON Film-coated tablet Ref.[9717] Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom

Product name and form

Opilon 40mg tablets.

Pharmaceutical Form
A pale yellow film-coated tablet.

Qualitative and quantitative composition

Each tablet contains moxisylyte hydrochloride 45.22mg (equivalent to moxisylyte base 40mg).

List of Excipients
Lactose Colloidal silicon dioxide Microcrystalline cellulose Magnesium stearate Maize starch The film coating contains: Methylhydroxypropylcellulose Propylene glycol Opaspray M-1-22900 (E464, E171, E104, E124 and E132) Water

Pack sizes and marketing

Blister pack comprising white PVC and aluminium foil backing containing 112 tablets.

Marketing authorization holder

Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom

Marketing authorization dates and numbers

PL 16508/0060

1 May 1999

Drugs

Drug	Countries
OPILON	United Kingdom

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.